Matt Glover

Health Economist. Surrey Health Economics Centre @uniofsurrey

[Matt Glover @Matt0G]

Super interesting to be involved in this mixed methods study looking at staffing and quality in care homes.

We investigated whether outcomes (e.g falls, UTI) were associated with levels of nurse staffing. They were, but seemingly a small effect, with relative high costs.

[Matt Glover @Matt0G]

Great to be part of this study, investigating bystander use of video streaming at the scene of incidents.

People were willing and able to use it - also raises interesting considerations about how to do a future economic evaluation.

Neat video summary: https://t.co/VBhvAu9ruR

[Matt Glover @Matt0G]

New paper on AAA screening in @ISPORJournals. Always great to collaborate with @michaelsweeting and colleagues on these projects investigating optimising screening.

[Michael Sweeting @michaelsweeting]

Great working with @Matt0G @Matt_J_Bown @Vascularexpert on "Evaluating the Cost-Effectiveness of Changes to the Surveillance Intervals in the UK Abdominal Aortic Aneurysm Screening Programme". https://t.co/zMIWJ6I54c

[National Institute for Health and Care Research @NIHRresearch]

A new ground-breaking #NIHRfunded trial led by researchers at @UniofNottingham will look at reducing the transmission and severity of #COVID19 in care homes: https://t.co/7WspkJJ8IS

@ProtectTrial @MedicineUoN

[Brunel Global Health Academy @health_brunel]

Join the team! 4 year Research Assistant/Fellow in Health Economics vacancy - working with Dr Nana Anokye @SubhashPokhrel @hergbrunel @BrunelGlobal @BrunelResearch

https://t.co/aEx6X1BVYv

Closes 22/09

[HERG Brunel @hergbrunel]

Places still available for short and advanced courses on economic evaluation / modelling in healthcare #healtheconomics @Healtheconall https://t.co/0PRxnBiOht

[Matt Glover @Matt0G]

Adaptation of model developed for RESCAN collaboration in UK for AAA screening in NZ. Authors suggest likely to be cost-effective. #HTA #Markovmodel #healtheconomics

[BJS @BJSurgery]

🆕Health gains, costs and cost‐effectiveness of a population‐based screening programme for abdominal aortic aneurysms - #Markov model from 🇳🇿

#AAA #VascularSurgery #SoMe4Surgery #QALY #CostEffectiveness #HealthScreening #SurgicalResearch

🔗https://t.co/j4HopnHMl0

[Michael Sweeting @michaelsweeting]

Great to see that the Screening Women for AAA (SWAN) project has been summarised as an NIHR Signal.

[HERG Brunel @hergbrunel]

Why is it worth spending money on medical research: lessons from building an evidence-base by Martin Buxton @hergbrunel & @jonathancgrant
https://t.co/kyaGinE07y

[Michael Sweeting @michaelsweeting]

The full HTA report. Screening women aged 65 years or over for abdominal aortic aneurysm: a modelling study and health economic evaluation https://t.co/KlZ2lULDvd

[The Lancet @TheLancet]

"By #UK standards, an #AAA screening programme for women, designed to be similar to that used to screen men, is unlikely to be cost-effective."

Analysis of clinical benefit, harms, and cost-effectiveness of screening women for abdominal aortic aneurysm https://t.co/UOApp4hrkX

[Matt Glover @Matt0G]

I like this! A video abstract our recent SWAN study findings. Is it effective and cost-effective to screen women for AAA?

[Matt Bown @Matt_J_Bown]

And there's a video abstract available at https://t.co/6Q9E6lYc5K

Thanks to @a_saratzis @UoLCVS @LeicResearch for the website.

[Matt Glover @Matt0G]

@michaelsweeting @Matt_J_Bown @IMPROVETrial @ScHARRSheffield Absolutely! Was great to be involved with.

[Subhash Pokhrel @SubhashPokhrel]

Ideal for health care commissioners and purchasers including CCGs; health care providers at all levels; clinical and health service researchers; colleagues from NICE and similar bodies in other countries; professionals from pharmaceutical and devices industries; PhD/PG students. https://t.co/QY3YnEIuSU

[Michael Sweeting @michaelsweeting]

Flexibility of discrete event simulation models for decision modelling in health care
https://t.co/lJQV0oRMZH

[Matt Glover @Matt0G]

New article online in @MedDecMak with colleagues @Cambridge_Uni Dept PH&PC: Discrete event simulation and Markov Models - lessons from AAA screening. https://t.co/i9b52xUv9D @hergbrunel @OfficialNIHR #HEcon #AAA

[HARPS Journal @HarpsJournal]

Recent research from @HarpsJournal featured in a blog 'Bang for your buck: the return from public investments in biomedical and health research' https://t.co/NoFvHDJBB6 from @jonathancgrant @Monty_E Martin Buxton and Matthew Glover

[Matt Glover @Matt0G]

Latest economic returns from medical research study, in MSD. Net health gain return of 7% (cancer 10%, CVD 9%) https://t.co/ENsK1q2s5h #impact #ROI @hergbrunel @policyatkings

[Arthritis UK @arthritisukorg]

What is medical research worth? In a study supported by @acmedsci @wellcometrust @The_MRC @OfficialNIHR we demonstrate the outstanding return on investment in #medicalresearch https://t.co/G8vDGsB4zh

[Matt Glover @Matt0G]

@ChrisNFloyd @wellcometrust @AMRC @The_MRC @OfficialNIHR and a total £1m of return after 4 years...